Name: |
PANTOPRAZOLE (PantolocR) |
Classification: |
proton pump inhibitor (PPI)
- inhibits the gastric H KATPase enzyme (the proton pump) that is responsible for acid secretion by the parietal cells of the stomach, resulting in increased gastric pH
- increased gastric pH desired for the prevention of stress-induced gastric ulceration and in the promotion of coagulation and platelet function in bleeding peptic ulcer disease
|
Dose: |
- maintenance dose: 40 mg IV once daily or BID
- bleeding peptic ulcer: 80 mg IV bolus followed by continuous infusion at 8 mg/hr
may need to decrease dose if significant hepatic dysfunction |
Administration: |
- Bolus: 40-80 mg in 100 mL sodium chloride 0.9%, dextrose 5% or Ringer's Lacate infused over 15-60 minutes
- Infusion:
- 40 mg in 100 mL sodium chloride 0.9%, dextrose 5% or Ringer's Lacate
- bag stable only for 6 hours; do not prepare large size bag
|
Adverse Effects:
|
Neurological:
- headache, dizziness, lack of energy
- depression, insomnia or somnolence, nervousness
- paresthesia
Dermatologic:
- acne, edema
- puritis, maculopapular rash, urticaria
- exfoliative dermatitis
- alopecia
Gastrointestinal:
- diarrhea, constipation
- increased appetite, dry mouth
Musculoskeletal:
- weakness, muscle spasms
- arthralgia, tremors, numbness
- elevated creatinine kinase
Ocular:
Renal/GU:
|
Monitoring Therapy: |
- bowel movements, stools for occult blood
- skin condition
|
CCTC Protocol: |
- May be administered IV direct or by IV infusion by a nurse in Adult Critical Care
- Continuous infusions must be administered by infusion device and the pump library must be enabled.
|
|
Lynne Kelly, Pharmacist, CCTC
Brenda Morgan, Clinical Nurse Specialist, CCTC
Last Update: October 11, 2018
|